Amplar Health, a healthcare service group under ASX-listed private insurer Medibank, has been tapped as a key partner to the Australian government’s virtual aged care nursing trial.The Department of Health and Aged Care chose…
Continue Reading
Rajneesh Patil Vice President, Digital Innovation at IQVIA
Nicholas Whitney, Senior Director, Site Suite, IQVIA Technologies
In recent years, clinical research and development stakeholders have put tremendous effort into improving patient-centered clinical trials, where patients feel…
Continue Reading
BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates genomic therapies for neurodegenerative diseases.Unlearn, founded in 2017, uses…
Continue Reading
Although promising, the clinical impact of video conferencing between primary and secondary care specialists lacks trial evidence. We conducted a two-arm RCT (clinicaltrials.gov: NCT05268081) to evaluate whether four video conferences over 12 months between…
Continue Reading
Infectious disease specialists (IDS) improve outcomes of patients with Staphylococcus bacteremia, but immediate IDS access is not always guaranteed. We investigated whether a care-integrated computerized decision support system (CDSS) can safely enhance the standard…
Continue Reading
Background: Numerous mobile apps have been developed for patients with cancer. However, there is still no comprehensive app for patients with breast cancer that integrates evidence-based medical information, psychological support, and schedule management through…
Continue Reading
Evinova, a clinical trial technology company, is partnering with Quantum Leap Healthcare Collaborative (QLHC) to integrate Evinova’s remote patient monitoring (RPM) offering into I-SPY 2.2, a platform trial that provides a framework to study…
Continue Reading
What You Should Know:
– The pharmaceutical research and development (R&D) sector is experiencing a significant upswing, with projected returns on investment climbing to 5.9% in 2024, according to a new report by Deloitte.
– This…
Continue Reading
Building accurate prediction models and identifying predictive biomarkers for treatment response in Muscle-Invasive Bladder Cancer (MIBC) are essential for improving patient survival but remain challenging due to tumor heterogeneity, despite numerous related studies. To…
Continue Reading
